GATA3 Expression in Advanced Breast Cancer: Prognostic Value and Organ-Specific Relapse
Open Access
- 1 November 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 144 (5) , 756-763
Abstract
Objectives. GATA3 is a transcription factor regulating luminal cell differentiation in the mammary glands and has been implicated in the luminal typesKeywords
This publication has 35 references indexed in Scilit:
- Expression of GATA3 in MDA-MB-231 Triple-negative Breast Cancer Cells Induces a Growth Inhibitory Response to TGFßPLOS ONE, 2013
- Breast carcinomas with isolated bone metastases have different hormone receptor expression profiles than those with metastases to other sites or multiple organsAnnals of Diagnostic Pathology, 2011
- Higher levels of GATA3 predict better survival in women with breast cancerHuman Pathology, 2010
- GATA3 in development and cancer differentiation: Cells GATA have it!Journal of Cellular Physiology, 2009
- CDK Inhibitor p18INK4c Is a Downstream Target of GATA3 and Restrains Mammary Luminal Progenitor Cell Proliferation and TumorigenesisCancer Cell, 2009
- GATA-3 Links Tumor Differentiation and Dissemination in a Luminal Breast Cancer ModelCancer Cell, 2008
- GATA-3 Maintains the Differentiation of the Luminal Cell Fate in the Mammary GlandCell, 2006
- Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer StudyJAMA, 2006
- Generation of a functional mammary gland from a single stem cellNature, 2006
- Purification and unique properties of mammary epithelial stem cellsNature, 2006